Prevention and treatment of pain using antibodies to lysophosphatidic acid
View Patent ↗Methods for preventing or treating pain are provided. Such methods comprise administering to a subject (e.g., a human subject) an antibody or antibody fragment that binds LPA. The antibody may be a humanized monoclonal antibody.
1. A method of reducing neuropathic pain or pain associated with chemotherapy, comprising administering to a subject having neuropathic pain or pain associated with chemotherapy, an antibody or antibody fragment that binds and neutralizes lysophosphatidic acid, thereby reducing said neuropathic pain or pain associated with chemotherapy.
2. A method according to claim 1 wherein the antibody or antibody fragment is a monoclonal antibody or monoclonal antibody fragment.
3. A method according to claim 2 wherein the antibody or antibody fragment is a humanized monoclonal antibody or antibody fragment of a humanized monoclonal antibody.
4. A method according to claim 1 wherein the subject is a human subject.